InventisBio Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	180.53	168.79	185.53	-	-	-
Revenue Growth (YoY)	132.90%	-9.02%	-	-	-	-
Cost of Revenue	0.96	3.92	-	-	-	-
Gross Profit	179.56	164.87	185.53	-	-	-
Selling, General & Admin	41.84	52.5	60.85	57.96	47.71	23.69
Research & Development	278.32	384.35	442.91	461.49	315.04	1,005
Other Operating Expenses	7.18	0.09	0.12	-0	0.05	0.27
Operating Expenses	348.17	445.82	513.18	519.44	362.8	1,029
Operating Income	-168.61	-280.95	-327.65	-519.44	-362.8	-1,029
Interest Expense	-0.66	-0.66	-0.83	-1.03	-1.19	-
Interest & Investment Income	32.44	30.02	40.45	17.38	12.76	0.72
Currency Exchange Gain (Loss)	1.56	1.56	1.18	19.99	-11.33	-27.37
Other Non Operating Income (Expenses)	-0.05	-0.11	-0.27	-0.2	-0.21	-0.08
EBT Excluding Unusual Items	-135.32	-250.14	-287.12	-483.31	-362.76	-1,056
Gain (Loss) on Sale of Investments	1.92	1.3	-	-	-	0.17
Gain (Loss) on Sale of Assets	0.08	0.08	-	-	0	-
Other Unusual Items	17.18	8.57	3.15	-0.18	4.85	2.31
Pretax Income	-116.14	-240.2	-283.98	-483.49	-357.91	-1,053
Net Income	-116.28	-240.2	-283.98	-483.49	-357.91	-1,053
Net Income to Common	-116.28	-240.2	-283.98	-483.49	-357.91	-1,053
Shares Outstanding (Basic)	583	576	575	509	459	460
Shares Outstanding (Diluted)	583	576	575	509	459	460
Shares Change (YoY)	1.23%	0.26%	12.97%	10.91%	-0.25%	-
EPS (Basic)	-0.20	-0.42	-0.49	-0.95	-0.78	-2.29
EPS (Diluted)	-0.20	-0.42	-0.49	-0.95	-0.78	-2.29
Free Cash Flow	-123.71	-249.53	-314.04	-484.59	-278.59	-202.83
Free Cash Flow Per Share	-0.21	-0.43	-0.55	-0.95	-0.61	-0.44
Gross Margin	99.47%	97.67%	100.00%	-	-	-
Operating Margin	-93.40%	-166.45%	-176.61%	-	-	-
Profit Margin	-64.41%	-142.31%	-153.06%	-	-	-
Free Cash Flow Margin	-68.53%	-147.84%	-169.27%	-	-	-
EBITDA	-163.05	-275.49	-322.31	-514.77	-360.15	-1,028
EBITDA Margin	-90.32%	-163.21%	-173.73%	-	-	-
D&A For EBITDA	5.56	5.47	5.34	4.68	2.64	0.98
EBIT	-168.61	-280.95	-327.65	-519.44	-362.8	-1,029
EBIT Margin	-93.40%	-166.45%	-176.61%	-	-	-
Revenue as Reported	180.53	168.79	185.53	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.